0000000000224016

AUTHOR

Michel Fardeau

showing 6 related works from this author

156th ENMC International Workshop: desmin and protein aggregate myopathies, 9-11 November 2007, Naarden, The Netherlands.

2008

Pathologymedicine.medical_specialtyProtein aggregationBiologyDesminNeurologyMuscular DiseasesPediatrics Perinatology and Child HealthmedicineMyotilinHumansDesminNeurology (clinical)Muscle SkeletalGenetics (clinical)Neuromuscular disorders : NMD
researchProduct

121st ENMC International Workshop on Desmin and Protein Aggregate Myopathies. 7–9 November 2003, Naarden, The Netherlands

2004

The 121st European Neuromuscular Centre (ENMC)sponsored International Workshop on ‘DESMIN and Protein Aggregate Myopathies’, attended by 16 active participants from France, Germany, Poland, Spain, Sweden, the United Kingdom and the USA, was actually the fourth one in a row addressing the pathology of the muscle fibre intermediate filament desmin, its associated and similar diseases, all four [1–3] organized by Michel Fardeau and Hans H. Goebel. In his introduction, the chairman, Hans H. Goebel (Mainz), recorded the evolution of ‘Protein Aggregate Myopathies (PAM)’ which are marked by the accumulation of diverse proteins within muscle fibres as a morphologic hallmark in separate myopathies w…

Pathologymedicine.medical_specialtyProtein aggregationBiologymedicine.diseaseNemaline myopathyNeurologyPediatrics Perinatology and Child HealthmedicineCongenital muscular dystrophyMyotilinDesminNeurology (clinical)Muscle fibremedicine.symptomMyopathyIntermediate filamentGenetics (clinical)Neuromuscular Disorders
researchProduct

Desmin – Protein Surplus Myopathies, 96th European Neuromuscular Centre (ENMC)-sponsored International Workshop held 14–16 September 2001, Naarden, T…

2002

medicine.medical_specialtyNeurologybusiness.industryFamily medicinePediatrics Perinatology and Child HealthmedicineDesminNeurology (clinical)businessGenetics (clinical)Neuromuscular Disorders
researchProduct

Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.

2000

Emery-Dreifuss muscular dystrophy (EDMD) is characterized by early contractures of the elbows and Achilles tendons, slowly progressive muscle wasting and weakness, and life-threatening cardiomyopathy with conduction blocks. We recently identified LMNA encoding two nuclear envelope proteins, lamins A and C, to be implicated in the autosomal dominant form of EDMD. Here, we report on the variability of the phenotype and spectrum of LMNA mutations in 53 autosomal dominant EDMD patients (36 members of 6 families and 17 sporadic cases). Twelve of the 53 patients showed cardiac involvement exclusively, although the remaining 41 all showed muscle weakness and contractures. We were able to identify …

AdultMaleContractureAdolescentGenotypeBiopsyNonsense mutationDNA Mutational AnalysisEmerinMutation MissenseLaminopathyBiologyLMNACardiovascular Physiological PhenomenamedicineMissense mutationHumansEmery–Dreifuss muscular dystrophyMuscular dystrophyAge of OnsetChildCreatine KinasePhysical ExaminationMuscle contractureAgedGenes DominantGeneticsMuscle WeaknessMyocardiumNuclear ProteinsHeartMiddle Agedmedicine.diseaseLamin Type ALaminsMuscular Dystrophy Emery-DreifussPedigreeMuscular AtrophyPhenotypeNeurologyDisease ProgressionFemaleNeurology (clinical)Gene DeletionAnnals of neurology
researchProduct

Myopathy with hexagonally cross-linked crystalloid inclusions: delineation of a clinico-pathological entity.

2010

A novel myopathy characterized by hexagonally cross-linked tubular arrays has been reported in five patients. We studied the clinical and histopathological features of five additional unrelated patients with this myopathy. Patients experienced exercise intolerance with exercise-induced myalgia and weakness, without rhabdomyolysis. One patient additionally presented mild permanent pelvic girdle muscle weakness. Age at onset varied between 13 and 56 years. The inclusions were eosinophilic on H and E, bright red with modified Gomori’s trichrome stains, present in type 2 fibers, and revealed immunoreactivity selectively for a caveolin-3-antibody. Ultrastructurally, the inclusions showed a highl…

myalgiaAdultMaleWeaknessPathologymedicine.medical_specialtyAdolescentCaveolin 3Blotting WesternExercise intoleranceNemaline myopathyMuscular DiseasesTrichromemedicineHumansAge of OnsetMyopathyMuscle SkeletalCreatine KinaseExerciseGenetics (clinical)Muscle Weaknessbusiness.industryMuscle weaknessMiddle Agedmedicine.diseaseImmunohistochemistryPhenotypeNeurologyPediatrics Perinatology and Child HealthFemaleNeurology (clinical)medicine.symptombusinessRhabdomyolysisNeuromuscular disorders : NMD
researchProduct

Desmin-related myopathy with mallory body-like inclusions is caused by mutations of the selenoprotein N gene

2004

Desmin-related myopathies (DRMs) are a heterogeneous group of muscle disorders, morphologically defined by intrasarcoplasmic aggregates of desmin. Mutations in the desmin and the alpha-B crystallin genes account for approximately one third of the DRM cases. The genetic basis of the other forms remain unknown, including the early-onset, recessive form with Mallory body-like inclusions (MB-DRMs), first described in five related German patients. Recently, we identified the selenoprotein N gene (SEPN1) as responsible for SEPN-related myopathy (SEPN-RM), a unique early-onset myopathy formerly divided in two different nosological categories: rigid spine muscular dystrophy and the severe form of c…

Genetics0303 health scienceseducation.field_of_studyPathologymedicine.medical_specialtySelenoprotein NLocus (genetics)Muscle disorderBiologymedicine.disease03 medical and health sciences0302 clinical medicineNeurologyCrystallinmedicineDesminNeurology (clinical)Muscular dystrophymedicine.symptomeducationMyopathyGene030217 neurology & neurosurgery030304 developmental biologyAnnals of Neurology
researchProduct